Treatment With Metformin in Chinese Children With Alport Syndrome

Clinical trial NCT05655728 · UNKNOWN

Trial details

NCT number: NCT05655728
Sponsor: Peking University First Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Alport Syndrome Metformin

Start date: 2023-01-03
Primary completion: 2025-01-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.